Table 1 Baseline characteristics of BC patients and cancer-free controls
From: Cardiovascular disease in women with breast cancer – a nationwide cohort study
BC patients | Cancer-free controls | ||||
|---|---|---|---|---|---|
Stage ≤ III (diagnosed without distant metastasis)a | Stage = IV (diagnosed with distant metastasis) | Stage unknown | Total | ||
N = 12,715 | N = 997 | N = 2793 | N = 16,505 | N = 165,042 | |
Age group | |||||
< 45 | 11% | 6% | 7% | 10% | 10% |
45–54 | 21% | 12% | 16% | 20% | 20% |
55–64 | 31% | 25% | 23% | 29% | 29% |
65–74 | 21% | 27% | 19% | 21% | 21% |
75+ | 15% | 29% | 35% | 19% | 19% |
Region of residence | |||||
Northern Jutland | 10% | 10% | 10% | 10% | 10% |
Central Jutland | 21% | 22% | 19% | 20% | 20% |
Southern Denmark | 23% | 19% | 26% | 23% | 23% |
Capital | 30% | 29% | 31% | 30% | 30% |
Zealand | 16% | 20% | 15% | 16% | 16% |
Education | |||||
Low | 38% | 49% | 37% | 38% | 38% |
Medium | 39% | 30% | 32% | 37% | 37% |
High | 19% | 11% | 14% | 18% | 18% |
Unknown | 4% | 10% | 17% | 6% | 6% |
Cancer treatment started within 9 months from BC diagnosis | |||||
Surgery | 96% | 63% | 81% | 91% | N.a. |
Chemotherapy | 35% | 37% | 22% | 33% | N.a. |
Radiation therapy | 62% | 28% | 34% | 55% | N.a. |
Antibody therapy | 4% | 7% | 2% | 4% | N.a. |
Hormonal therapy | 41% | 38% | 26% | 39% | N.a. |